Polyneuropathies: Clinical Trials

705 trials for Polyneuropathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

311 completed, 147 recruiting, 88 unknown, 57 terminated. 158 Phase 2, 137 Not applicable, 90 Phase 3, 88 Phase 1, 23 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2158Completed 71, Terminated 24, Recruiting 22, Active not recruiting 10, Not yet recruiting 10, Unknown 10, Withdrawn 9, Enrolling by invitation 1, Suspended 1
Not applicable137Completed 63, Recruiting 28, Unknown 20, Active not recruiting 8, Withdrawn 8, Terminated 5, Not yet recruiting 3, Enrolling by invitation 2
Phase 390Completed 42, Recruiting 15, Unknown 11, Terminated 10, Not yet recruiting 6, Withdrawn 4, Active not recruiting 1, Enrolling by invitation 1
Phase 188Completed 42, Recruiting 20, Terminated 13, Active not recruiting 4, Not yet recruiting 3, Withdrawn 3, Unknown 2, Suspended 1
Phase 423Completed 9, Unknown 9, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Early Phase 111Completed 4, Recruiting 4, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Polyneuropathies: new trials by email Literature Review of Polyneuropathies trials Research Report on Polyneuropathies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A
scAAV1.tMCK.NTF3 - Charcot-Marie-Tooth Neuropathy Type 1A
Phase 1 / Phase 2WithdrawnNationwide Children's Hospital2027-04-012026-07-29
A Study of Empasiprubart as Add-On Therapy to IVIg in Adult Participants With Guillain-Barré Syndrome
Empasiprubart IV, Empasiprubart Placebo IV, Intravenous immunoglobulin (IVIg) - Guillain-Barré Syndrome (GBS)
Phase 2Not yet recruitingargenx632026-12-012026-09-25
Muscle MRI Fat Fraction Before Surgery to Predict Strength Recovery After Foot-Drop Surgery in Charcot-Marie-Tooth Disease
Tibialis posterior tendon transfer, Individualized adjunct procedures for cavovarus deformity correction, Ankle-foot orthosis (AFO) - Foot Drop, Charcot-Marie-Tooth Disease Type 1A
Not yet recruitingPeking University Third Hospital1002026-12-012026-10-26
Clinical, Electrophysiological and Genetic Characteristics of Hereditary and Inflammatory Polyneuropathies in France
Genetic and Inflammatory Polyneuropathies
Not yet recruitingAssistance Publique - Hôpitaux de Paris10002026-11-012026-10-01
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
Acoramidis (AG10) - Amyloidosis in Transthyretin (TTR), Amyloidosis, Familial
Phase 3Not yet recruitingEidos Therapeutics, a BridgeBio company2502026-11-012026-08-11
Peripheral Nerve Ultrasound in Children With Guillain-Barré Syndrome
Guillain-Barre Syndrome
Not yet recruitingAssiut University422026-10-102026-10-08
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immune globulin (human) 10% solution for intravenous administration - Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3RecruitingKedrion S.p.A.1612026-10-012026-09-11
Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating Polyneuropathy
Xsens motion suit - CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
Not yet recruitingHeinrich-Heine University, Duesseldorf502026-10-012026-10-20
Rare Disease Registry Database for Movement Disorders in Southern Anhui Province
Motor Neuron Diseases, Spinocerebellar Ataxias
RecruitingFirst Affiliated Hospital of Wannan Medical College1802026-09-302026-10-23
Myocardial Changes in Pediatric Guillain-Barré Syndrome
Myocardial Dysfunction, Guillain-Barre Syndrome
Not yet recruitingAssiut University722026-09-262026-09-25
Comparative Effectiveness of Nursing Interventions: Using Buerger-Allen Exercises Versus Mechanical Compression Therapy on Lower Limb Perfusion and Peripheral Neuropathy Among Patients Undergoing Chemotherapy.
mechanical compression therapy, Exercises - Polyneuropathies, Regional Blood Flow
Not applicableActive not recruitingDamanhour University1002026-09-062026-09-30
Single-Center Study Evaluating the Impact of Age on the Diagnostic Performance of the Sural-to-Radial Sensory Amplitude Ratio in Length-Dependent and Non-Length-Dependent Peripheral Polyneuropathies
Retrospective Medical Record Review - Polyneuropathies, Electromyography
Not yet recruitingCentre Hospitalier Universitaire de Nice1802026-09-012026-07-24
Ultrasound-driven Stratification in CIDP
Refractory CIDP, Standard-of-care treatment for CIDP - CIDP, Chronic Inflammation
Not yet recruitingCentre Hospitalier Universitaire de Nice302026-09-012026-07-22
A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Empasiprubart IV - Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Phase 2 / Phase 3Not yet recruitingargenx62026-09-012026-06-10
Efficacy and Safety of Efgartigimod in the Treatment of Guillain-Barré Syndrome(GREAT)
Intravenous immunoglobulin (IVIG), Efgartigimod Alfa-Fcab - Guillain-Barré Syndrome
Phase 2Not yet recruitingBeijing Tiantan Hospital1102026-09-012026-09-18
Concurrent Training vs Soleus Push-Ups on Neurogenesis-Related Biomarkers in Diabetic Neuropathy Patients
Concurrent Training, Soleus Push-ups - Diabetic Peripheral Neuropathy Type 2
Not applicableNot yet recruitingRiphah International University992026-09-012026-06-30
Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)
Everolimus, Tacrolimus or Cyclosporine - Liver Allograft, Liver Diseases
Phase 3RecruitingHannover Medical School1502026-08-192026-10-05
Postoperative Circulating Tumor DNA Monitoring in Stage I-III Driver-Mutant Colon Adenocarcinoma
Longitudinal ctDNA-MRD NGS testing at scheduled postoperative time points - Colon Adenocarcinoma, Stage I Colon Cancer
RecruitingRuijin Hospital3922026-08-142026-09-02
Cryotherapy, PGE2, NGF Levels and Pain After Endodontic Retreatment
Intracanal cryotherapy, Room-temperature saline irrigation - Asymptomatic Apical Periodontitis, Endodontic Retreatment
Not applicableNot yet recruitingAlanya Alaaddin Keykubat University1002026-08-012026-07-29
Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy?
Polyneuropathies, Diabetic Complications Neurological
Not yet recruitingGÜLDEN ANATACA812026-07-302026-07-29

Showing 20 of 705. Sign in to see all of them.

Narrower conditions

Hereditary Sensory and Autonomic Neuropathies (174)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (136)  ·  Charcot-Marie-Tooth Disease (112)  ·  Guillain-Barre Syndrome (95)  ·  Spastic Paraplegia, Hereditary (49)  ·  Peripheral Nervous System Diseases (34)  ·  Breast Neoplasms (24)  ·  Neuromuscular Diseases (24)  ·  Amyloidosis (23)  ·  Myasthenia Gravis (23)  ·  Multiple Sclerosis (22)  ·  Diabetic Neuropathies (18)  ·  Pain (18)  ·  Amyotrophic Lateral Sclerosis (17)

Broader conditions

Nervous System Diseases (695)  ·  Neuromuscular Diseases (681)  ·  Peripheral Nervous System Diseases (671)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (398)  ·  Neurodegenerative Diseases (392)  ·  Genetic Diseases, Inborn (377)  ·  Congenital Abnormalities (368)  ·  Heredodegenerative Disorders, Nervous System (365)  ·  Nervous System Malformations (353)  ·  Pathological Conditions, Signs and Symptoms (345)  ·  Pathologic Processes (275)  ·  Immune System Diseases (262)  ·  Disease Attributes (248)  ·  Demyelinating Diseases (226)

Interventions

Immunoglobulins, Intravenous (24)  ·  Fulvestrant (10)  ·  Alpelisib (9)  ·  Everolimus (8)  ·  Immunoglobulins (8)  ·  Rituximab (8)  ·  Blood Specimen Collection (7)  ·  Saline Solution (7)  ·  tanezumab (7)  ·  Cetuximab (6)  ·  Cyclophosphamide (6)  ·  Dexamethasone (6)  ·  Hizentra (6)  ·  Nerve Growth Factor (6)  ·  Exercise (5)

Sponsors

Pfizer (15)  ·  Novartis Pharmaceuticals (14)  ·  NYU Langone Health (13)  ·  Assiut University (12)  ·  Assistance Publique - Hôpitaux de Paris (10)  ·  AstraZeneca (10)  ·  argenx (10)  ·  University of Aarhus (9)  ·  Centre Hospitalier Universitaire de Nice (6)  ·  Istituto Clinico Humanitas (6)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (6)  ·  CSL Behring (5)  ·  IRCCS Eugenio Medea (5)  ·  Takeda (5)  ·  Tongji Hospital (5)

Countries

United States (264)  ·  France (115)  ·  Germany (89)  ·  Italy (88)  ·  Spain (73)  ·  United Kingdom (70)  ·  China (59)  ·  Canada (57)  ·  Denmark (49)  ·  Netherlands (48)  ·  Belgium (37)  ·  Japan (35)  ·  Turkey (Türkiye) (33)  ·  Australia (31)  ·  Poland (31)

Top investigators

Horacio Kaufmann, MD (5)  ·  Michael E Shy, MD (4)  ·  Adeline Vanderver, MD (2)  ·  Alejandra Gonzalez-Duarte, MD (2)  ·  David Herrmann, MBBCh (2)

Results publications

PMID 42578463, PMID 30936738, PMID 26554876, PMID 31353964, PMID 32107748, PMID 37460782, PMID 18178525, PMID 24327518, PMID 25519680, PMID 27424289, PMID 27494299, PMID 28672195, PMID 29023494, PMID 29115008, PMID 29383130, PMID 29846250, PMID 30558645, PMID 31101621, PMID 31533931, PMID 31831767, PMID 31882719, PMID 31894292, PMID 37395948, PMID 38353301, PMID 38507752, PMID 38729747, PMID 41491634, PMID 10411196, PMID 10540002, PMID 11232233, PMID 11344264, PMID 1135616, PMID 11382253, PMID 11383973, PMID 12084892, PMID 12235608, PMID 12437775, PMID 12473512, PMID 12671856, PMID 12851579, PMID 12959218, PMID 13211501, PMID 14564276, PMID 14610153, PMID 15607214, PMID 15610704, PMID 15680560, PMID 15703014, PMID 1577335, PMID 16267188

NIH funding

2025 (8), 2018 (7), 2023 (6), 2017 (5), 2019 (5), 2009 (4), 2016 (4), U54NS065712 (4), 2015 (3), 2008 (2), U01TR001263 (2), U54NS092091 (2), 2005 (1), 2014 (1), 5RC1NS068179-02 (1)